Bryan Leaw
  • English

Tel: +61 3 8618 4187


  • Melbourne

Bryan Leaw is an associate in our Melbourne biotechnology team.

Bryan spent eight years in cutting-edge translational research, and in 2016 was made a Churchill Fellow (CF) for his achievements in the biomedical field. Bryan has advised on a range of inventions from breakthrough anti-cancer drugs, CAR-T therapies, anti-inflammatory compositions, embryonic stem cells, to modified clinical dosage regimes for pharmaceuticals.


Technical Group:

Read Bryan's full bio


  • Masters of Intellectual Property Law, The University of Melbourne
  • PhD (Neuroscience), The University of Melbourne
  • Graduate Certificate in Research Commercialisation, Melbourne Business School
  • Bachelor of Biomedical Science, The University of Melbourne
  • Bachelor of Science (Hons), The University of Melbourne

Industry Expertise

  • Regenerative medicine such as stem cells and tissue engineering
  • Biologics, such as antibodies and proteins
  • Neuroscience and its disorders, particularly epilepsy, stroke and cerebral palsy
  • Diagnostics
  • Pharmaceuticals

Professional Affiliations

  • Member – Institute of Patent and Trade Mark Attorneys Australia (IPTA)
  • Member - Intellectual Property Society of Australia and New Zealand (IPSANZ)
  • Member - AusBiotech
  • Member - VESKI Connection